Last Updated: September 24, 2026

Orphalan Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORPHALAN

ORPHALAN has one approved drug.

There are five US patents protecting ORPHALAN drugs.

Summary for Orphalan

US Patents:	5
Tradenames:	1
Ingredients:	1
NDAs:	1
Patent Litigation for Orphalan:	See patent lawsuits for Orphalan

Drugs and US Patents for Orphalan

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes	12,358,861	⤷ Start Trial	Y	Y		⤷ Start Trial
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes	12,662,445	⤷ Start Trial	Y	Y		⤷ Start Trial
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes	11,072,577	⤷ Start Trial				⤷ Start Trial
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes	10,988,436	⤷ Start Trial		Y		⤷ Start Trial
Orphalan	CUVRIOR	trientine tetrahydrochloride	TABLET;ORAL	215760-001	Apr 28, 2022		RX	Yes	Yes	12,358,862	⤷ Start Trial	Y	Y		⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Orphalan Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Lithuania	3652145	⤷ Start Trial
China	114394904	⤷ Start Trial
Taiwan	202604878	⤷ Start Trial
Japan	2025037978	⤷ Start Trial
Portugal	3652145	⤷ Start Trial
South Korea	102843554	⤷ Start Trial
South Korea	20210005270	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Orphalan

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.